Activity trends of the largest Russian pharmaceutical wholesalers

trends 24.09.2019

Information agency Credinform represents an overview of activity trends of the largest Russian pharmaceutical wholesalers.

Trading companies with the largest volume of annual revenue (TOP-10 and TOP-1000) were selected for the analysis, according to the data from the Statistical Register for the latest available periods (for 2015 – 2017). The analysis was made on the basis of the data of the Information and Analytical system Globas.

Net assets value is an indicator, reflecting the real value of company’s property, is calculated annually as the difference between assets on the enterprise balance and its debt obligations. The indicator of net assets is considered negative (insufficiency of property), if company’s debt exceeds the value of its property.

The largest company in terms of net assets is OTCPHARM NJSC. In 2018, its net assets amounted to more than 51,4 billion rubles.

The smallest amount of net assets in the TOP-1000 list was hold by NJSC ROSTA. The insufficiency of property of this company in 2017 was expressed as a negative value of -13,5 billion rubles.

The average values of net assets tend to increase over the ten-year period (Picture 1).

Picture 1. Change in the industry average indicators of the net asset value of pharmaceutical wholesalers in 2008 – 2017 Picture 1. Change in the industry average indicators of the net asset value of pharmaceutical wholesalers in 2008 – 2017

The shares of TOP-1000 enterprises with insufficiency of assets have a tendency to decrease in the last five years (Picture 2).

Picture 2. Shares of enterprises with negative values of net assets in TOP-1000 in 2013 – 2017 Picture 2. Shares of enterprises with negative values of net assets in TOP-1000 in 2013 – 2017

Sales revenue
The revenue volume of 10 leading companies of the industry made 35% of the total revenue of TOP-1000 in 2017 (Picture 3). It points to a relatively high level of competition in the industry.

Picture 3. Shares of participation of TOP-10 companies in the total revenue of TOP-1000 enterprises for 2017 Picture 3. Shares of participation of TOP-10 companies in the total revenue of TOP-1000 enterprises for 2017

In general, there is a decrease in industry average revenue over the ten-year period (Picture 4).

Picture 4. Change in the industry average revenue of pharmaceutical wholesalers in 2008 – 2017 Picture 4. Change in the industry average revenue of pharmaceutical wholesalers in 2008 – 2017

Profit and loss
The largest company in terms of net profit value is JSC PHARMSTANDARD. The company's profit amounted to more than 45,5 billion rubles for 2018.

Industry average values of net profit trend to increase over the past ten years (Picture 5).

Picture 5. Change in the industry average indicators of net profit of pharmaceutical wholesalers in 2008 – 2017 Picture 5. Change in the industry average indicators of net profit of pharmaceutical wholesalers in 2008 – 2017

Average values of net profit’s indicators of TOP-1000 companies increase for the five-year period, at the same time the average value of net loss increases significantly. (Picture 6).

Picture 6. Change in the industry average values of indicators of net profit and net loss of TOP-1000 companies in 2015 – 2017 Picture 6. Change in the industry average values of indicators of net profit and net loss of TOP-1000 companies in 2015 – 2017

Key financial ratios
Over the ten-year period the average indicators of the total liquidity ratio of TOP-1000 enterprises were in the range of recommended values - from 1,0 up to 2,0, with a tendency to increase (Picture 7).

The total liquidity ratio (the relation of the amount of current assets to short-term liabilities) shows the sufficiency of company’s funds for repayment of its short-term liabilities.

Picture 7. Change in the industry average values of the total liquidity ratio of pharmaceutical wholesalers in 2008 – 2017 Picture 7. Change in the industry average values of the total liquidity ratio of pharmaceutical wholesalers in 2008 – 2017

The average industry values of the return on investment ratio were mainly at a relatively high level with the tendency to increase over the course of ten years (Picture 8).

The ratio is calculated as the relation of net profit to the sum of own capital and long-term liabilities and demonstrates the return on the equity of own capital involved in the commercial activity and the long-term borrowed funds of an organization.

Picture 8. Change in the industry average values of the return on investment ratio of pharmaceutical wholesalers in 2008 – 2017 Picture 8. Change in the industry average values of the return on investment ratio of pharmaceutical wholesalers in 2008 – 2017

Asset turnover ratio is calculated as the relation of sales proceeds to the average value of total assets for a period and characterizes the efficiency of use of all available resources, regardless of the sources of their attraction. The ratio shows how many times a year a complete cycle of production and circulation is made, yielding profit.

This ratio of business activity showed a tendency to decrease over the ten-year period (Picture 9).

Picture 9. Change in the industry average values of the asset turnover ratio of pharmaceutical wholesalers in 2008 – 2017 Picture 9. Change in the industry average values of the asset turnover ratio of pharmaceutical wholesalers in 2008 – 2017

Small business
66% of TOP-1000 companies are registered in the Register of small and medium-sized enterprises of the Federal Tax Service of the RF. At the same time, their share in the total revenue amounted to 14,5% in 2017, that is significantly lower than the national average (Picture 10).

Picture 10. Shares of proceeds of small and medium-sized enterprises in TOP-1000 companies, % Picture 10. Shares of proceeds of small and medium-sized enterprises in TOP-1000 companies, %

Main regions of activity
The TOP-1000 companies are distributed highly unequal across Russia and registered in 69 regions. Almost 69% of their revenues are concentrated in Moscow and Moscow region (Picture 11).

Picture 11. Distribution of the revenue of TOP-1000 companies by Russian regions Picture 11. Distribution of the revenue of TOP-1000 companies by Russian regions

Financial position score
An assessment of the financial position of TOP-1000 companies shows that the financial position of most of them is above average (Picture 12).

Picture 12. Distribution of TOP-1000 companies by financial position score Picture 12. Distribution of TOP-1000 companies by financial position score

Solvency index Globas
The vast majority of TOP-1000 companies got Superior/High or Strong/Medium Solvency index Globas, that points to their ability to pay off their debts in time and fully (Picture 13).

Picture 13. Distribution of TOP-1000 companies by solvency index Globas Picture 13. Distribution of TOP-1000 companies by solvency index Globas

Conclusion
A comprehensive assessment of activity of pharmaceutical wholesalers, taking into account the main indices, financial indicators and ratios, points to the prevalence of positive trends in the industry (Table 1).

Table 1. Positive and negative trends, evaluation factors of the industry
Trends and evaluation factors Specific share of factor, %
Rate of growth (decline) in the average size of net assets up10
Increase / decrease in the share of enterprises with negative values of net assets up10
Level of competition up5
Rate of growth (decline) in the average size of revenue down-10
Rate of growth (decline) in the average size of profit (loss) up10
Growth / decline in average values of net profit of TOP-1000 companies up10
Growth / decline in average values of net loss of TOP-1000 companies down-10
Increase / decrease in average values of total liquidity ratio up10
Increase / decrease in average values of return on investment ratio up10
Increase / decrease in average values of asset turnover ratio down-10
Share of small and medium-sized enterprises in the industry in terms of revenue being more than 22% down-10
Regional concentration down-10
Financial position (the largest share) up10
Solvency index Globas (the largest share) up10
Average value of factors up2,5

Up positive trend (factor), Down negative trend (factor).